p53 Efficiently Suppresses Tumor Development in the Complete Absence of Its Cell-Cycle Inhibitory and Proapoptotic Effectors p21, Puma, and Noxa
Liz J Valente, Daniel HD Gray, Ewa M Michalak, Josefina Pinon-Hofbauer, Alex Egle, Clare L Scott, Ana Janic, Andreas Strasser
Cell Reports | CELL PRESS | Published : 2013
Awarded by National Health and Medical Research Council of Australia
Awarded by Leukemia and Lymphoma Society
Awarded by Career Development Fellowship
Work in the authors' laboratories was supported by the National Health and Medical Research Council of Australia (Program Grant 461221, Australia Fellowship), the Leukemia and Lymphoma Society (SCOR grant #7413), the Career Development Fellowship #637353 to D.H.D.G.), the Cancer Council Victoria (to L.J.V.), the Beatriu de Pinos Foundation and the Lady Tata Memorial Trust (to A.J.), and operational infrastructure grants through the Australian Government (IRISS) and the Victorian State Government (OIS). We thank Drs. Y. Haupt and K. Wolyniec (Peter MacCallum Cancer Center, Melbourne, Australia) for reagents and advice.